Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response

被引:20
作者
Derdelinckx, I [1 ]
Van Laethem, K
Maes, B
Schrooten, Y
De Wit, SP
Florence, E
Fransen, K
Ribas, SG
Marissens, D
Moutschen, M
Vaira, D
Zissis, G
Van Ranst, M
Van Wijngaerden, E
Vandamme, AM
机构
[1] REGA, Inst Med Res, Louvain, Belgium
[2] Univ Hosp Leuven, Louvain, Belgium
[3] Univ St Pierre, Ctr Hosp Sint Pieter, Med Ctr, Brussels, Belgium
[4] Inst Trop Med, B-2000 Antwerp, Belgium
[5] CHU Liege, Liege, Belgium
关键词
D O I
10.1097/00126334-200412150-00022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1664 / 1666
页数:3
相关论文
共 5 条
[1]   BRIEF REPORT - PRIMARY INFECTION WITH ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
ERICE, A ;
MAYERS, DL ;
STRIKE, DG ;
SANNERUD, KJ ;
MCCUTCHAN, FE ;
HENRY, K ;
BALFOUR, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (16) :1163-1165
[2]   Time trends in primary HIV-1 drug resistance among recently infected persons [J].
Grant, RM ;
Hecht, FM ;
Warmerdam, M ;
Liu, L ;
Liegler, T ;
Petropoulos, CJ ;
Hellmann, NS ;
Chesney, M ;
Busch, MP ;
Kahn, JO .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (02) :181-188
[3]   Antiretroviral-drug resistance among patients recently infected with HIV [J].
Little, SJ ;
Holte, S ;
Routy, JP ;
Daar, ES ;
Markowitz, M ;
Collier, AC ;
Koup, RA ;
Mellors, JW ;
Connick, E ;
Conway, B ;
Kilby, M ;
Wang, L ;
Whitcomb, JM ;
Hellmann, NS ;
Richman, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :385-394
[4]   Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients [J].
Palella, FJ ;
Chmiel, JS ;
Moorman, AC ;
Holmberg, SD .
AIDS, 2002, 16 (12) :1617-1626
[5]  
WENSING AMJ, 2003, PROGRAM ABSTRACTS 2, P13